These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 731812)

  • 21. [Effect of cellulose phosphate on urinary excretion of calcium in patients with nephrolithiasis].
    Pietrek J; Kokot F
    Pol Arch Med Wewn; 1973 Jan; 50(1):29-37. PubMed ID: 4686047
    [No Abstract]   [Full Text] [Related]  

  • 22. Physiological basis for absorptive and renal hypercalciurias.
    Pak CY
    Am J Physiol; 1979 Dec; 237(6):F415-23. PubMed ID: 229736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of recurrent calcium stone formation with cellulose phosphate.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1980 Jan; 123(1):9-13. PubMed ID: 7351731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
    Takei K; Ito H; Masai M; Kotake T
    Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diethylaminoethanol-cellulose in the treatment of absorptive hyperoxaluria.
    Pinto B; Bernshtam J
    J Urol; 1978 May; 119(5):630-2. PubMed ID: 660734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ion-exchange substances in the prevention of recurrence of calcium kidney stones].
    Schneider HJ; Rugendorff EW
    Arch Esp Urol; 1983; 36(2):124-32. PubMed ID: 6625683
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.
    Pak CY; Delea CS; Bartter FC
    N Engl J Med; 1974 Jan; 290(4):175-80. PubMed ID: 4808916
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: Calcium nephrolithiasis and cellulose phosphate.
    Williams HE
    N Engl J Med; 1974 Jan; 290(4):224-5. PubMed ID: 4808920
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
    Robertson WG; Peacock M
    Nephron; 1980; 26(3):105-10. PubMed ID: 7412965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones.
    Bataille P; Charransol G; Gregoire I; Daigre JL; Coevoet B; Makdassi R; Pruna A; Locquet P; Sueur JP; Fournier A
    J Urol; 1983 Aug; 130(2):218-23. PubMed ID: 6876264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of calcium metabolism in normal persons and patients with hypercalciuria in relation to therapy with the dietary fiber preparation Farnolith].
    Strohmaier WL; Bichler KH; Kalchthaler M
    Urologe A; 1989 Jan; 28(1):11-4. PubMed ID: 2538020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and chemical factors in kidney calculus formation in childhood. An analysis of 40 patients].
    Böhles H; Brandl U; Schott G; Stehr K
    Monatsschr Kinderheilkd; 1984 Mar; 132(3):158-62. PubMed ID: 6727888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of stone growth and urinary biochemistry in long-term follow-up of stone patients with idiopathic hypercalciuria.
    Marickar YM; Rose GA
    Br J Urol; 1985 Dec; 57(6):613-7. PubMed ID: 4084717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a 5-year treatment program in patients with hyperoxaluric stones.
    Pinto B; Ruiz-Marcellán FJ; Bernshtam J
    J Urol; 1983 Nov; 130(5):943-5. PubMed ID: 6632105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
    Schwille PO; Hanisch E; Scholz D
    J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperoxaluria or hypercalciuria in nephrolithiasis: the importance of renal tubular functions.
    Lindsjö M; Fellström B; Danielson BG; Kasidas GP; Rose GA; Ljunghall S
    Eur J Clin Invest; 1990 Oct; 20(5):546-54. PubMed ID: 2124987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
    Woelfel A; Kaplan RA; Pak CY
    Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.